Radiotracer, Gamma Camera Study Of Chemotherapy: Results “Scinti”-llating
This article was originally published in The Gray Sheet
Executive Summary
Patients responding to neoadjuvant chemotherapy can reliably be identified using the radiotracer Tc99m sestamibi (DuPont's Cardiolite) and a gamma camera like Philips Medical Systems' Prism 2000 XP, according to a study published in the June issue of The Journal of Nuclear Medicine
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.